Risk for primary cephalosporin resistance in Gram-negative bacteremia.

Princy JohnSona Shahbazian William D Lainhart Justin F Hayes Brian Mochon David E Nix

Published in: Antimicrobial stewardship & healthcare epidemiology : ASHE (2023)

Patients without the identified risk factors should be strongly considered for receiving ceftriaxone or cefepime rather than carbapenems and newer broad-spectrum agents.

Keyphrases

gram negative
multidrug resistant
risk factors
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis